1	Regulation	regulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	megakaryocytic	megakaryocytic	_	_	_	_	_	_	_
5	glycoprotein	glycoprotein	_	_	_	_	_	_	_
6	IX	ix	_	_	_	_	_	_	_
7	promoter	promoter	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	oncogenic	oncogenic	_	_	_	_	_	_	_
11	Ets	Ets	_	_	_	_	_	_	_
12	transcription	transcription	_	_	_	_	_	_	_
13	factor	factor	_	_	_	_	_	_	_
14	Fli-1	fli-1	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Glycoprotein	Glycoprotein	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	GP	GP	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	IX	ix	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	subunit	subunit	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	von	von	_	_	_	_	_	_	_
12	Willebrand	Willebrand	_	_	_	_	_	_	_
13	receptor	receptor	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	GPIb-V-IX	GPIb-V-IX	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	which	which	_	_	_	_	_	_	_
18	mediates	mediate	_	_	_	_	_	_	_
19	adhesion	adhesion	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	platelets	platelet	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	subendothelium	subendothelium	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	damaged	damage	_	_	_	_	_	_	_
27	blood	blood	_	_	_	_	_	_	_
28	vessels	vessel	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	Previous	previous	_	_	_	_	_	_	_
2	characterization	characterization	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	GPIX	GPIX	_	_	_	_	_	_	_
6	promoter	promoter	_	_	_	_	_	_	_
7	identified	identify	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	functional	functional	_	_	_	_	_	_	_
10	Ets	ets	_	_	_	_	_	_	_
11	site	site	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	when	when	_	_	_	_	_	_	_
15	disrupted	disrupt	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	reduced	reduce	_	_	_	_	_	_	_
18	promoter	promoter	_	_	_	_	_	_	_
19	activity	activity	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	Ets	Ets	_	_	_	_	_	_	_
5	protein(s)	protein(s)	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	regulated	regulate	_	_	_	_	_	_	_
8	GPIX	GPIX	_	_	_	_	_	_	_
9	promoter	promoter	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	unknown	unknown	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	transient	transient	_	_	_	_	_	_	_
6	cotransfection	cotransfection	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	several	several	_	_	_	_	_	_	_
9	GPIX	GPIX	_	_	_	_	_	_	_
10	promoter/reporter	promoter/reporter	_	_	_	_	_	_	_
11	constructs	construct	_	_	_	_	_	_	_
12	into	into	_	_	_	_	_	_	_
13	293T	293t	_	_	_	_	_	_	_
14	kidney	kidney	_	_	_	_	_	_	_
15	fibroblasts	fibroblast	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	Fli-1	fli-1	_	_	_	_	_	_	_
19	expression	expression	_	_	_	_	_	_	_
20	vector	vector	_	_	_	_	_	_	_
21	shows	show	_	_	_	_	_	_	_
22	that	that	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	oncogenic	oncogenic	_	_	_	_	_	_	_
25	protein	protein	_	_	_	_	_	_	_
26	Fli-1	fli-1	_	_	_	_	_	_	_
27	can	can	_	_	_	_	_	_	_
28	transactivate	transactivate	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	GPIX	GPIX	_	_	_	_	_	_	_
31	promoter	promoter	_	_	_	_	_	_	_
32	when	when	_	_	_	_	_	_	_
33	an	an	_	_	_	_	_	_	_
34	intact	intact	_	_	_	_	_	_	_
35	GPIX	GPIX	_	_	_	_	_	_	_
36	Ets	Ets	_	_	_	_	_	_	_
37	site	site	_	_	_	_	_	_	_
38	is	be	_	_	_	_	_	_	_
39	present	present	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	Fli-1	fli-1	_	_	_	_	_	_	_
5	binding	binding	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	GPIX	GPIX	_	_	_	_	_	_	_
9	Ets	Ets	_	_	_	_	_	_	_
10	site	site	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	identified	identify	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	antibody	antibody	_	_	_	_	_	_	_
15	supershift	supershift	_	_	_	_	_	_	_
16	experiments	experiment	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	nuclear	nuclear	_	_	_	_	_	_	_
19	extracts	extract	_	_	_	_	_	_	_
20	derived	derive	_	_	_	_	_	_	_
21	from	from	_	_	_	_	_	_	_
22	hematopoietic	hematopoietic	_	_	_	_	_	_	_
23	human	human	_	_	_	_	_	_	_
24	erythroleukemia	erythroleukemia	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Comparative	comparative	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	showed	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	Fli-1	fli-1	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	also	also	_	_	_	_	_	_	_
8	able	able	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	transactivate	transactivate	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	GPIbalpha	GPIbalpha	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	lesser	less	_	_	_	_	_	_	_
18	extent	extent	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	GPIIb	GPIIb	_	_	_	_	_	_	_
22	promoter	promoter	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Immunoblot	Immunoblot	_	_	_	_	_	_	_
2	analysis	analysis	_	_	_	_	_	_	_
3	identified	identify	_	_	_	_	_	_	_
4	Fli-1	fli-1	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	lysates	lysate	_	_	_	_	_	_	_
8	derived	derive	_	_	_	_	_	_	_
9	from	from	_	_	_	_	_	_	_
10	platelets	platelet	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	Fli-1	Fli-1	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	identified	identify	_	_	_	_	_	_	_
9	immunohistochemically	immunohistochemically	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	megakaryocytes	megakaryocyte	_	_	_	_	_	_	_
12	derived	derive	_	_	_	_	_	_	_
13	from	from	_	_	_	_	_	_	_
14	CD34(+)	cd34(+)	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	treated	treat	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	megakaryocyte	megakaryocyte	_	_	_	_	_	_	_
20	differentiation	differentiation	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	proliferation	proliferation	_	_	_	_	_	_	_
23	factor	factor	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	thrombopoietin	thrombopoietin	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	Fli-1	fli-1	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	likely	likely	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	regulate	regulate	_	_	_	_	_	_	_
10	lineage-specific	lineage-specific	_	_	_	_	_	_	_
11	genes	gene	_	_	_	_	_	_	_
12	during	during	_	_	_	_	_	_	_
13	megakaryocytopoiesis	megakaryocytopoiesis	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

